DadFinStart your free week
DadFin › Stocks › Consumer Defensive › EPC

Edgewell Personal Care Company (EPC) stock score

Consumer Defensive · Household & Personal Products · United States

$27.80 ▲ +0.25% today

47.4
Dad Score, out of 100
middling

Edgewell Personal Care Company (EPC) is a Household & Personal Products company in the Consumer Defensive sector, listed in the United States. On DadFin's weekly run it scores 47.4 out of 100 on the Dad Score, a middling reading that places the business ahead of 47% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Consumer Defensive it ranks #107 of 232. Its strongest axes are valuation and price action; its weakest are growth and risk.

Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Above average
Quality
Average
Growth
Below average
Price action
Above average
Risk
Weak
Conviction
Below average
Liquidity
Weak
Macro
Weak

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)0.0×
P/E (forward)13.4×
Dividend yield2.25%
Return on capital3.0%
Operating margin8.8%
Revenue growth (YoY)-1.3%
FCF yield1.7%
Net debt / EBITDA3.35×
Piotroski F-Score5 / 9
52-week change+39.2%
Market cap$1.2B
Next earningsNov 12, 2026

What subscribers see on EPC

Start your free weekSubscriber? Open the full research →

Household & Personal Products peers

StockCompanyDad ScoreBandMarket cap
PGThe Procter & Gamble Company46.1middling$336.8B
ULUnilever PLC34.5weak$128.6B
CLColgate-Palmolive Company26.7weak$67.2B
ELThe Estée Lauder Companies Inc.53.8middling$33.3B
KVUEKenvue Inc.53.1middling$33.0B
KMBKimberly-Clark Corporation21.9weak$31.3B
CHDChurch & Dwight Co., Inc.59.6middling$22.4B
CLXThe Clorox Company8.9poor$9.7B

Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.